Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Jan 27 2026

The Company has informed the Exchange regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.

View Attachment

Earlier from Caplin Point Laboratories

All Caplin Point Laboratories news releases